KLS Martin Will Reach 500 Bioceramic Implants by 2026
The manufacturer expects to hit a key milestone for its patient-specific implant platform by the end of Q3 2026.
Updated on Sept. 19, 2026 in Biotech
Live Poll
Would you prefer a 3D-printed custom medical implant if one were recommended by your surgeon?
KLS Martin is expanding its use of bioceramic implants through its IPS Gate digital planning platform. The company projects it will have delivered 500 of these custom surgical scaffolds by the end of Q3 2026.
Why it matters
The company’s digital workflow allows surgeons to quickly convert patient CT scans into custom implants, improving the speed of care. This technology leverages advanced 3D printing to create precise geometries tailored to individual anatomical needs.
KLS Martin utilizes Lithography-based Ceramic Manufacturing 3D printers and Lithoz LithaBone TCP material to create these scaffolds. The process allows for the creation of intricate geometries and specific porosity levels in the implants.
The players
KLS Martin
Based in Germany, this company manufactures surgical devices and manages the IPS Gate digital planning platform.
Lithoz
Headquartered in Vienna, this manufacturer provides 3D printing technology for ceramic materials and has partnered with KLS Martin for 12 years.
The details
The IPS Gate platform integrates into the existing digital planning workflow, shortening the time from medical imaging to the production of a finished implant. The company also utilizes the SonicWeld Rx system, which features resorbable polymer pins, to handle the fixation of these devices.
Timeline
Lithoz was founded in 2011.
Lithoz secured ISO 13485 certification in 2025.
KLS Martin expects to reach 500 delivered implants by the end of Q3 2026.
The Tech Race
The transition toward 3D-printed, patient-specific bioceramics marks a significant shift away from mass-produced, off-the-shelf surgical implants. This evolution positions firms using Lithography-based Ceramic Manufacturing to capture market share in complex orthopedic and reconstructive surgeries.
Patients may benefit from faster surgical planning and implants that better match their specific anatomical requirements. Surgeons using the IPS Gate platform can expect a more streamlined digital workflow that reduces the delay between initial medical scans and the procedure.
The takeaway
Advancements in 3D-printed medical devices are shortening the gap between patient diagnostic data and finished surgical hardware. These technologies represent a broader move toward hyper-personalized medicine where implants are custom-tailored rather than standardized.
Further reading
Explore the latest developments in surgical innovation on our Biotech section page.
Source note: This article includes information reported by 3D Printing Industry.
Live Poll
Would you prefer a 3D-printed custom medical implant if one were recommended by your surgeon?
